Production (Stage)
Cognition Therapeutics, Inc.
CGTX
$0.322
$0.02377.95%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.76% | -31.73% | -50.12% | -36.89% | -21.22% |
| Total Depreciation and Amortization | 1.20% | 5.56% | 6.10% | 6.22% | 4.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.22% | -15.60% | -0.51% | 10.60% | 11.21% |
| Change in Net Operating Assets | -135.69% | -73.42% | 249.32% | 98.86% | 193.91% |
| Cash from Operations | -51.32% | -77.76% | -23.15% | -37.79% | -12.64% |
| Capital Expenditure | 96.23% | 97.28% | 74.02% | 1.09% | -35.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 96.23% | 97.28% | 74.02% | 1.09% | -35.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 13.17% | 8.88% | 13.62% | 26.39% | 35.32% |
| Issuance of Common Stock | -14.17% | 383.14% | 91.96% | 66.38% | 154.71% |
| Repurchase of Common Stock | 35.85% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -22.13% | 421.23% | 102.42% | 76.52% | 193.66% |
| Foreign Exchange rate Adjustments | -- | -- | -100.00% | -75.00% | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -340.76% | 57.79% | 19.67% | -0.89% | 67.41% |